April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Concentration and Composition Changes in Heparan Sulfate Increase Complement Activation Through Modulation of C3bBb Convertase Formation and This Effect is Modified by Factor H
Author Affiliations & Notes
  • Una L. Kelly
    Ophthalmology,
    Duke University Eye Center, Durham, North Carolina
  • Jin-Dong Ding
    Ophthalmology,
    Duke University Eye Center, Durham, North Carolina
  • Kent Y. Feng
    Ophthalmology,
    Duke University Eye Center, Durham, North Carolina
  • Haixiang Jiang
    Pediatrics,
    Duke University Eye Center, Durham, North Carolina
  • Michael Frank
    Pediatrics,
    Duke University Eye Center, Durham, North Carolina
  • Catherine Bowes Rickman
    Ophthalmology and Cell Biology,
    Duke University Eye Center, Durham, North Carolina
  • Footnotes
    Commercial Relationships  Una L. Kelly, None; Jin-Dong Ding, None; Kent Y. Feng, None; Haixiang Jiang, None; Michael Frank, None; Catherine Bowes Rickman, None
  • Footnotes
    Support  NIH Grant EY019038, P30 EY005722, Research to Prevent Blindness,Inc., Ruth and Milton Steinbach Fund, Macular Vision Research Foundation
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2301. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Una L. Kelly, Jin-Dong Ding, Kent Y. Feng, Haixiang Jiang, Michael Frank, Catherine Bowes Rickman; Concentration and Composition Changes in Heparan Sulfate Increase Complement Activation Through Modulation of C3bBb Convertase Formation and This Effect is Modified by Factor H. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2301. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Allotypic variations in complement factor H (CFH) increase the risk of developing age-related macular degeneration (AMD), yet there has been little evidence of significant functional differences between the disease-associated allotypic variant of CFH, V62/H402, and the protective variant, I62/Y402. This study tests the hypothesis that AMD risk conferred by CFH is modulated by components of the extracellular matrix of Bruch’s membrane, particularly heparan sulfate glycosaminoglycans (HS GAGs), and that allotypic differences in CFH will only be detectable if CFH, C3, and GAG interactions are studied together in functional assays.

Methods: : Two assays were used in this study: (1) a convertase assembly assay that detects the conversion of C3 to C3b, and Factor B to Bb and (2) a fluorescence-based assay that measures the extent of unfolding of C3 in the presence of HS-GAGs. Electron microscopy was used to detect age-dependent changes in HS in human eyes.

Results: : We found that HS binds to C3 and C3b, changing their conformation such that factor B can no longer bind to C3b or undergo factor D mediated cleavage to form the convertase C3bBb, thereby blocking complement activation. We established the minimum HS concentration threshold for this effect and found that it is dependent on the HS source and chemical modifications. We also show that CFH competes with C3 for binding to HS and that this alters the concentration threshold for C3 denaturation by HS. In addition, in human and in mouse, HS distribution in Bruch’s membrane changes with age.

Conclusions: : We have recently shown that HS accelerates the rate of factor I-mediated cleavage of C3b (Kelly et al. J.Immunol. 2010). This study extends the effects HS to C3bBb formation, reinforcing the importance of the GAG composition in the Bruch’s membrane/choroid region of the eye. Taken together, our results suggest that alterations in the GAG composition that occur as a part of aging potentially make this tissue more vulnerable to damaging complement activation.

Keywords: age-related macular degeneration • proteoglycans/glycosaminoglycans • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×